Alkermes Plc (ALKS)

Exchange
NASDAQ
Symbol
ALKS
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Alkermes plc, a biopharmaceutical company, researches, develops and markets pharmaceutical products to address the unmet medical needs of patients in various therapeutic areas in the United States, Ireland and internationally. The company is headquartered in Dublin, Ireland.
Country
USA

Stock price

At close: November 5, 2024

  • Open
    27.87
  • High
    28.46
  • Low
    27.29
  • Close
    28.37
  • Volume
    2,472,280

Financial ratios

Jun 30, 2024

Activity ratios
Inventory turnover
3.70
Receivables turnover
4.06
Payables turnover
6.88
Working capital turnover
1.45
Days of inventory on hand (DOH)
98.58
Days of sales outstanding (DSO)
89.80
Number of days of payables
53.03
Fixed asset turnover
6.69
Total asset turnover
0.67
 Liquidity ratios
Current ratio
2.99
Quick ratio
2.41
Cash ratio
1.70
Cash conversion cycle
135.35
 Solvency ratios
Debt-to-assets ratio
0.13
Debt-to-capital ratio
0.18
Debt-to-equity ratio
0.22
Financial leverage ratio
1.72
Interest coverage
10.36
 Profitability ratios
Gross profit margin
26.69%
Operating profit margin
25.22%
Pretax margin
15.07%
Net profit margin
19.39%
Operating return on assets (Operating ROA)
17.02%
Return on assets (ROA)
13.08%
Return on total capital
15.82%
Return on equity (ROE)
22.49%